Stanford researchers have developed a personalized arrhythmia risk prediction tool for dilated cardiomyopathy (DCM) patients using patient-derived induced pluripotent stem cells (iPSCs) to replicate heart biology and accurately predict arrhythmia risk, enabling timely interven
Researchers at Stanford have created the first small primate model to study human heart rhythm disorders and also discovered a new way the heart keeps its beat.
Stanford scientists have developed a generative learning framework paired with a compact wearable EMG device that extrapolates limited sensor inputs to reconstruct muscle activity equivalent to that captured by high-density sensor arrays.
Stanford researchers have developed an innovative, non-invasive therapeutic strategy to treat myocardial fibrosis (MF), a key driver of arrhythmia and heart failure in LMNA-related dilated cardiomyopathy (LMNA-DCM).
Stanford researchers have developed the Large-scale Electrophysiology Amplification Platform (LEAP), a wireless, label-free optical system for monitoring the electrical activity of neurons and heart cells.
Stanford scientists have developed waterproofed six-axis robotic Stewart platforms that accurately replicate papillary muscle motion in ex vivo heart simulators.
Stanford scientists have developed a novel cardiac Ex-vivo Preservation System (EVPS) capable of maintaining hearts of any size warm and beating upon transport, expanding heart transplant options for pediatric populations.
Stanford inventors have developed an optimal strain sensing network for continuous monitoring of cardiac strains to monitor cardiac health and assess real-time response to therapies.
Stanford doctors have developed an innovative left ventricular decompression vent with multiple-channels design that significantly enhances blood removal during cardiac surgery.
Researchers at Stanford University have created a novel mitral valve annuloplasty ring that can be adjusted in size off-bypass in response to regurgitation.